NanoViricides Inc (NNVC)

May 16, 2025

Small cap wrap: NanoViricides, Trust Stamp, NextSource, StickIt... - Proactive financial news

May 16, 2025

May 16, 2025

NanoViricides advances NV-387 antiviral program, eyes Phase II trials for Mpox - Proactive financial news

May 16, 2025

May 16, 2025

NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectrum Antiviral NV-387 To Combat MPox Pandemic in AfricaPhase II Clinical Trial Update, Also Readying to Combat Measles Outbreaks, and to Tackle Bird Flu - The Derrick

May 16, 2025

May 16, 2025

NanoViricides: MPox ethics approval enables Phase 2 application - Proactive Investors

May 16, 2025

May 16, 2025

NanoViricides: Fiscal Q3 Earnings Snapshot - Huron Daily Tribune

May 16, 2025

May 14, 2025

Small cap wrap: atai, Black Swan Graphene, TNR Gold, NanoViricides... - Proactive financial news

May 14, 2025

May 14, 2025

NanoViricides progresses antiviral portfolio as measles and MPox threats rise - Proactive Investors

May 14, 2025

May 14, 2025

Measles Cases Are Increasing Globally; MPox Continues to Be a ThreatBroad-Spectrum Antiviral Drug Could Be the Solution - The Derrick

May 14, 2025

May 08, 2025

Small cap wrap: NanoViricides, Alvopetro, Polarean... - Proactive financial news

May 08, 2025

May 08, 2025

NanoViricides wins ethics approval for Phase II Mpox drug trial in DRC - Proactive financial news

May 08, 2025

May 08, 2025

Broad-Spectrum Antiviral Drug NV-387 Cleared for Phase II Clinical Trial Application by the National Ethics Committee of the Democratic Republic of Congo - The Derrick

May 08, 2025

May 07, 2025

Renaissance Technologies LLC Buys 30,800 Shares of NanoViricides, Inc. (NYSE:NNVC) - Defense World

May 07, 2025

May 05, 2025

NanoViricides to Present Innovative Antiviral Drug Research at D. Boral Capital Conference - citybuzz -

May 05, 2025

May 05, 2025

NanoViricides, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference, May 14th, NYC - The Globe and Mail

May 05, 2025

May 04, 2025

Geode Capital Management LLC Acquires 31,956 Shares of NanoViricides, Inc. (NYSE:NNVC) - Defense World

May 04, 2025

Apr 29, 2025

NanoViricides Advances Broad-Spectrum Antiviral Drug for Measles Treatment - citybuzz -

Apr 29, 2025

Apr 29, 2025

NanoViricides advances measles drug development amid rising US cases | NYSE-A:NNVC - Proactive financial news

Apr 29, 2025

Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025

Apr 29, 2025

Measles is Likely to Become EndemicNanoViricides Is Testing a Drug to Combat It - The Derrick

Apr 29, 2025

Apr 28, 2025

New research warns measles could become endemic again in the US as vaccination rates fall - Proactive financial news

Apr 28, 2025

Apr 25, 2025

"NanoViricides Broad Spectrum Technology Represents Potential Paradigm Shift In Viral Therapy"; "Novel Anti-Viral Could Boost a US$3 Billion Market"Conclude Two Independent Research Reports on NanoViricides - ACCESS Newswire

Apr 25, 2025

Apr 24, 2025

Nanostructured Drug Market Projected for Significant Expansion by 2032 -Nanoviricides Inc, Ablynx NV, Pfizer - newstrail.com

Apr 24, 2025

Apr 14, 2025

Small cap wrap: Gunnison Copper, Ocean Power Technologies, NanoViricides... - Proactive financial news

Apr 14, 2025

Apr 14, 2025

NanoViricides evaluating antiviral drug NV-387 for measles treatment - Proactive financial news

Apr 14, 2025

Apr 14, 2025

Measles Outbreak Expands Begging for a Drug to Treat the InfectionNanoViricides Declares it is Ready to Fight the Outbreak - Lelezard

Apr 14, 2025

Apr 12, 2025

NanoViricides, Inc. Appoints Irach Taraporewala as the New CEO and Nominates to Serve as a Member of the Board of Directors - marketscreener.com

Apr 12, 2025

Apr 09, 2025

Nanostructured Drug Market Detailed In New Research Report 2025 | Nanoviricides Inc., Ablynx NV, Pfizer - newstrail.com

Apr 09, 2025

Apr 08, 2025

NanoViricides Provides an Update on Its Clinical Program and StrategyNV-387 Could be As Revolutionary as Antibiotics - ACCESS Newswire

Apr 08, 2025

Apr 05, 2025

NanoViricides unaffected by US tariff turmoil, says CFO - Proactive financial news

Apr 05, 2025

Apr 05, 2025

NNVC stock touches 52-week low at $1.02 amid market challenges - Investing.com Canada

Apr 05, 2025

Apr 04, 2025

NanoViricides unimpacted by tariffs; sees boost by changes at government agencies - Proactive Investors

Apr 04, 2025

Apr 04, 2025

NNVC stock touches 52-week low at $1.02 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

NanoViricides highlights broad-spectrum antiviral strategy and progress with lead drug candidate - Proactive financial news

Apr 04, 2025

Mar 31, 2025

Virtu Financial LLC Acquires New Position in NanoViricides, Inc. (NYSE:NNVC) - Defense World

Mar 31, 2025

Mar 28, 2025

Small cap wrap: NanoViricides, G Mining Ventures, Nevis Brands... - Proactive Investors

Mar 28, 2025

Mar 28, 2025

NanoViricides eyes role in US bird flu fight as USDA unveils $100M initiative - Proactive Investors

Mar 28, 2025

Mar 25, 2025

NanoViricides Has Initiated Bio-analytical Studies as Part of IND-Enabling Safety and Toxicology Studies of Lead Candidate NV-HHV-101 - ACCESS Newswire

Mar 25, 2025

Mar 15, 2025

NanoViricides (NYSE:NNVC) Trading Up 1.7% – Time to Buy? - Defense World

Mar 15, 2025